Breast Cancer Drugs May Severely Inflame Lungs, FDA Warns Breast Cancer Drugs May Severely Inflame Lungs, FDA Warns

CDK 4/6 inhibitors may cause rare but severe inflammation of the lungs. Clinicians asked to watch for new or worsening respiratory symptoms.News Alerts
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Alert Source Type: news